Christine Marks
Corporate Officer/Principal chez SPECTRAL AI, INC.
Profil
Christine Marks is currently the Vice President of Marketing & Commercialization at Spectral AI, Inc. She previously worked as the Vice President of Sales & Marketing at Monarch Medical Technologies LLC and as the Vice President of Marketing & Commercialisation at Spectral MD Holdings Ltd.
She holds a Master's in Business Administration from Wake Forest University and an undergraduate degree from Appalachian State University.
Postes actifs de Christine Marks
Sociétés | Poste | Début |
---|---|---|
SPECTRAL AI, INC. | Corporate Officer/Principal | 01/04/2022 |
Anciens postes connus de Christine Marks
Sociétés | Poste | Fin |
---|---|---|
Monarch Medical Technologies LLC | Sales & Marketing | - |
Spectral MD Holdings Ltd.
Spectral MD Holdings Ltd. Packaged SoftwareTechnology Services Spectral MD Holdings Ltd. develops proprietary artificial intelligence algorithms and optical technology to help clinicians to make faster treatment decisions in wound care sector. Its DeepView Wound Imaging solution is an internally developed AI and multispectral imaging technology that enables the user to distinguish between damaged and healthy human tissue. The company was founded in 2009 and is headquartered in Dallas, TX. | Sales & Marketing | - |
Formation de Christine Marks
Wake Forest University | Masters Business Admin |
Appalachian State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
SPECTRAL AI, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Monarch Medical Technologies LLC | |
Spectral MD Holdings Ltd.
Spectral MD Holdings Ltd. Packaged SoftwareTechnology Services Spectral MD Holdings Ltd. develops proprietary artificial intelligence algorithms and optical technology to help clinicians to make faster treatment decisions in wound care sector. Its DeepView Wound Imaging solution is an internally developed AI and multispectral imaging technology that enables the user to distinguish between damaged and healthy human tissue. The company was founded in 2009 and is headquartered in Dallas, TX. | Technology Services |